Seems as if there is so little posting recently. I realize that there isn't too much to say, but almost no comments, even about today's Oppenheimer Healthcare web presentation by Mr. Hamelin and the third quarter 2009 financial results CC on Thursday. If we don't get any positive update about how we are proceeding relative to the concerns given in the CRL, especially the Krystexxa batches, the Israeli plant, and the REMS program, I see SVNT drifting even lower. The overall market will have its impact, a will Healthcare reform, however that may evolve.

Seem almost eerily quiet here now. I believe we have lost many of our long investors along the way, including some of the brightest and wisest ones.

Anyone out there? My dog is too busy looking for squirrels, chipmunks, deer, and rabbits to have any serious discussions on Savient, KRTSTEXXA, and FDA approval. I may have to start talking to myself even more than normal.



Lonely in Maryland,


Dooby